MSLN overexpression has been discovered in different tumors, including pancreatic cancer, in which almost 85% of cells express this protein[103], and of course up to 90% of mesothelioma cells are positive for MSLN[104]. This evidence concerns the gene MSLN and pancreatic neoplasm.